Xu et al. described germline mutations in FGFR4 i.e., glycine to arginine transition at position 388 in the transmembrane domain of FGFR4 receptor, which results in the formation of FGFR4 arg388 allele, leading to higher cancer risk [28]. Here, FGFR4 is linked to cancer.